The global market value of Alzheimer’s disease (AD) therapeutics could soar to the $8 billion range once therapeutics are approved that actually change the course of the disease. More than 150 companies are working on new treatments for AD, including approximately 15 multinationals and 30 generics companies. Which new therapies do you think will be most successful at treating AD?
Poll Question:
Which new Alzheimer’s disease treatments do you think have the best chance of success?
Bapineuzumab
14
Antisenilin
7
Gammagard
16
Gantenerumab
7
Other
33
